Achieve Life Sciences, Inc. Cash and Cash Equivalents, Period Increase (Decrease)
Achieve Life Sciences, Inc. (ACHV) reported Cash and Cash Equivalents, Period Increase (Decrease) of $8.01 million for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-09.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2017-11-09
- Achieve Life Sciences, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-09-30 was $9.32M, a 60.64% decline year-over-year.
- Achieve Life Sciences, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-06-30 was -$1.77M.
- Achieve Life Sciences, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-03-31 was $457.00K.
- Achieve Life Sciences, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2016-12-31 was -$19.04M.
- Achieve Life Sciences, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$19.08M, a 397.47% decline from fiscal 2015.
- Achieve Life Sciences, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2015 was $6.41M, a 51.80% decline from fiscal 2014.
- Achieve Life Sciences, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2014 was $13.30M.
- Achieve Life Sciences, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2013 was -$3.48M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|---|---|
| 2017-09-30 | $9.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $7.55M derived: sum of 2 quarters · filed 2017-11-09 | $8.01M 10-Q · filed 2017-11-09 | -$11.03M derived: sum of 4 quarters · filed 2017-11-09 | ||
| 2017-06-30 | -$1.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-31 | -$1.32M 10-Q · filed 2017-07-31 | -$20.35M derived: sum of 3 quarters · filed 2017-07-31 | $3.33M derived: sum of 4 quarters · filed 2017-11-09 | ||
| 2017-03-31 | $457.00K 10-Q · filed 2017-05-15 | -$18.58M derived: sum of 2 quarters · filed 2017-05-15 | $5.11M derived: sum of 3 quarters · filed 2017-11-09 | -$3.22M derived: sum of 4 quarters · filed 2017-11-09 | ||
| 2016-12-31 | -$19.04M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $4.65M derived: sum of 2 quarters · filed 2017-11-09 | -$3.68M derived: sum of 3 quarters · filed 2017-11-09 | -$19.08M 10-K · filed 2017-02-23 | ||
| 2016-09-30 | $23.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $15.36M derived: sum of 2 quarters · filed 2017-11-09 | -$40.00K 10-Q · filed 2017-11-09 | -$22.51M 10-Q · filed 2016-11-10 | -$8.21M derived: sum of 4 quarters · filed 2017-11-09 | |
| 2016-06-30 | -$8.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-31 | -$23.73M 10-Q · filed 2017-07-31 | -$31.90M derived: sum of 3 quarters · filed 2017-07-31 | -$37.42M derived: sum of 4 quarters · filed 2017-07-31 | ||
| 2016-03-31 | -$15.40M 10-Q · filed 2017-05-15 | -$23.56M derived: sum of 2 quarters · filed 2017-05-15 | -$29.09M derived: sum of 3 quarters · filed 2017-05-15 | -$6.37M derived: sum of 4 quarters · filed 2017-05-15 | ||
| 2015-12-31 | -$8.17M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$13.69M derived: sum of 2 quarters · filed 2017-02-23 | $9.03M derived: sum of 3 quarters · filed 2017-02-23 | $6.41M 10-K · filed 2017-02-23 | ||
| 2015-09-30 | -$5.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $17.20M derived: sum of 2 quarters · filed 2016-11-10 | $14.58M 10-Q · filed 2016-11-10 | -$6.47M derived: sum of 4 quarters · filed 2017-02-23 | ||
| 2015-06-30 | $22.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $20.10M 10-Q · filed 2016-08-04 | -$949.00K derived: sum of 3 quarters · filed 2017-02-23 | $7.39M derived: sum of 4 quarters · filed 2017-02-23 | ||
| 2015-03-31 | -$2.62M 10-Q · filed 2016-05-12 | -$23.67M derived: sum of 2 quarters · filed 2017-02-23 | -$15.34M derived: sum of 3 quarters · filed 2017-02-23 | -$3.35M derived: sum of 4 quarters · filed 2017-02-23 | ||
| 2014-12-31 | -$21.05M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$12.72M derived: sum of 2 quarters · filed 2017-02-23 | -$733.00K derived: sum of 3 quarters · filed 2017-02-23 | $13.30M 10-K · filed 2017-02-23 | ||
| 2014-09-30 | $8.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $20.32M derived: sum of 2 quarters · filed 2015-11-12 | $34.36M 10-Q · filed 2015-11-12 | $36.00M derived: sum of 4 quarters · filed 2016-03-09 | ||
| 2014-06-30 | $11.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $26.02M 10-Q · filed 2015-08-13 | $27.66M derived: sum of 3 quarters · filed 2016-03-09 | $21.86M derived: sum of 4 quarters · filed 2016-03-09 | ||
| 2014-03-31 | $14.04M 10-Q · filed 2015-05-14 | $15.68M derived: sum of 2 quarters · filed 2016-03-09 | $9.88M derived: sum of 3 quarters · filed 2016-03-09 | $10.00M derived: sum of 4 quarters · filed 2016-03-09 | ||
| 2013-12-31 | $1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-09 | -$4.16M derived: sum of 2 quarters · filed 2016-03-09 | -$4.04M derived: sum of 3 quarters · filed 2016-03-09 | -$3.48M 10-K · filed 2016-03-09 | ||
| 2013-09-30 | -$5.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | -$5.68M derived: sum of 2 quarters · filed 2014-10-30 | -$5.13M 10-Q · filed 2014-10-30 | $1.59M derived: sum of 4 quarters · filed 2015-03-26 | ||
| 2013-06-30 | $121.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $674.00K 10-Q · filed 2014-08-07 | $7.39M derived: sum of 3 quarters · filed 2015-03-26 | $4.91M derived: sum of 4 quarters · filed 2015-03-26 | ||
| 2013-03-31 | $553.00K 10-Q · filed 2014-04-30 | $7.27M derived: sum of 2 quarters · filed 2015-03-26 | $4.79M derived: sum of 3 quarters · filed 2015-03-26 | -$38.22M derived: sum of 4 quarters · filed 2015-03-26 | ||
| 2012-12-31 | $6.71M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26 | $4.23M derived: sum of 2 quarters · filed 2015-03-26 | -$38.78M derived: sum of 3 quarters · filed 2015-03-26 | -$10.44M 10-K · filed 2015-03-26 | ||
| 2012-09-30 | -$2.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | -$45.49M derived: sum of 2 quarters · filed 2013-11-07 | -$17.16M 10-Q · filed 2013-11-07 | -$4.36M derived: sum of 4 quarters · filed 2014-03-11 | ||
| 2012-06-30 | -$43.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | -$14.68M 10-Q · filed 2013-08-08 | -$1.88M derived: sum of 3 quarters · filed 2014-03-11 | -$7.03M derived: sum of 4 quarters · filed 2014-03-11 | ||
| 2012-03-31 | $28.34M 10-Q · filed 2013-05-02 | $41.13M derived: sum of 2 quarters · filed 2014-03-11 | $35.98M derived: sum of 3 quarters · filed 2014-03-11 | $49.85M derived: sum of 4 quarters · filed 2014-03-11 | ||
| 2011-12-31 | $12.79M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11 | $7.64M derived: sum of 2 quarters · filed 2014-03-11 | $21.52M derived: sum of 3 quarters · filed 2014-03-11 | $4.98M 10-K · filed 2014-03-11 | ||
| 2011-09-30 | -$5.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $8.72M derived: sum of 2 quarters · filed 2012-11-08 | -$7.81M 10-Q · filed 2012-11-08 | $3.94M derived: sum of 4 quarters · filed 2013-03-07 | ||
| 2011-06-30 | $13.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | -$2.66M 10-Q · filed 2012-08-02 | $2.66M 10-Q · filed 2011-08-05 | $9.10M derived: sum of 3 quarters · filed 2013-03-07 | -$70.22M derived: sum of 4 quarters · filed 2013-03-07 | |
| 2011-03-31 | -$16.54M 10-Q · filed 2012-05-03 | -$4.78M derived: sum of 2 quarters · filed 2013-03-07 | -$84.09M derived: sum of 3 quarters · filed 2013-03-07 | |||
| 2010-12-31 | $11.75M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07 | -$67.56M derived: sum of 2 quarters · filed 2013-03-07 | -$38.52M 10-K · filed 2013-03-07 | |||
| 2010-09-30 | -$79.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | -$50.27M 10-Q · filed 2011-11-03 | ||||
| 2010-06-30 | $29.04M 10-Q · filed 2011-08-05 | |||||
| 2009-12-31 | $54.43M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |